Image

PREdiction of succeSSful weanING From Continuous Renal Replacement Theraphy: the Possible Role of Delta C-cistatin

PREdiction of succeSSful weanING From Continuous Renal Replacement Theraphy: the Possible Role of Delta C-cistatin

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to know if, in patients with acute kidney injury, naive for renal injurie, admitted to different ICUs, the change in plasma concentration of c-cistatin, between initiation and discontinuation of CRRT, is a predictive finding to optimize the withdrawal time of renal support

Eligibility

Inclusion Criteria:

  • age ≥ 18 years;
  • diagnosis of acute kidney injury (defined according to KDIGO 2012 criteria)
  • need for support with CRRT according to the indications of the nephrologist consultants and Clinical Practice
  • Obtaining informed consent

Exclusion Criteria:

  • CRRT already ongoing (in another department not participating in the study) at the time of transfer/admission to intensive care;
  • need for RRT (any type and modality) in the 14 days prior to enrolment;
  • diagnosis of AKD/CKD/ESRF on admission;
  • Discontinuation of CRRT under conditions that do not comply with the criteria established by the study;
  • Need for CRRT not associated with AKI condition (e.g. elimination of toxicants);
  • pregnant women;
  • presence of known thyreopathy
  • Continuous use of corticosteroids
  • patient with known neoplastic disease.

Study details
    Acute Kidney Injury

NCT06714214

IRCCS Azienda Ospedaliero-Universitaria di Bologna

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.